Rho-related BTB domain-containing protein 2 (Deleted in breast cancer 2 gene protein) (p83)
1_MDSDM 6_ DYERP 11_ NVETI 16_ KCVVV 21_ GDNAV 26_ GKTRL 31_ ICARA 36_ CNATL 41_ TQYQL 46_ LATHV 51_ PTVWA 56_ IDQYR 61_ VCQEV 66_ LERSR 71_ DVVDD 76_ VSVSL 81_ RLWDT 86_ FGDHH 91_ KDRRF 96_ AYGRS 101_ DVVVL 106_ CFSIA 111_ NPNSL 116_ HHVKT 121_ MWYPE 126_ IKHFC 131_ PRAPV 136_ ILVGC 141_ QLDLR 146_ YADLE 151_ AVNRA 156_ RRPLA 161_ RPIKP 166_ NEILP 171_ PEKGR 176_ EVAKE 181_ LGIPY 186_ YETSV 191_ VAQFG 196_ IKDVF 201_ DNAIR 206_ AALIS 211_ RRHLQ 216_ FWKSH 221_ LRNVQ 226_ RPLLQ 231_ APFLP 236_ PKPPP 241_ PIIVV 246_ PDPPS 251_ SSEEC 256_ PAHLL 261_ EDPLC 266_ ADVIL 271_ VLQER 276_ VRIFA 281_ HKIYL 286_ STSSS 291_ KFYDL 296_ FLMDL 301_ SEGEL 306_ GGPSE 311_ PGGTH 316_ PEDHQ 321_ GHSDQ 326_ HHHHH 331_ HHHHG 336_ RDFLL 341_ RAASF 346_ DVCES 351_ VDEAG 356_ GSGPA 361_ GLRAS 366_ TSDGI 371_ LRGNG 376_ TGYLP 381_ GRGRV 386_ LSSWS 391_ RAFVS 396_ IQEEM 401_ AEDPL 406_ TYKSR 411_ LMVVV 416_ KMDSS 421_ IQPGP 426_ FRAVL 431_ KYLYT 436_ GELDE 441_ NERDL 446_ MHIAH 451_ IAELL 456_ EVFDL 461_ RMMVA 466_ NILNN 471_ EAFMN 476_ QEITK 481_ AFHVR 486_ RTNRV 491_ KECLA 496_ KGTFS 501_ DVTFI 506_ LDDGT 511_ ISAHK 516_ PLLIS 521_ SCDWM 526_ AAMFG 531_ GPFVE 536_ SSTRE 541_ VVFPY 546_ TSKSC 551_ MRAVL 556_ EYLYT 561_ GMFTS 566_ SPDLD 571_ DMKLI 576_ ILANR 581_ LCLPH 586_ LVALT 591_ EQYTV 596_ TGLME 601_ ATQMM 606_ VDIDG 611_ DVLVF 616_ LELAQ 621_ FHCAY 626_ QLADW 631_ CLHHI 636_ CTNYN 641_ NVCRK 646_ FPRDM 651_ KAMSP 656_ ENQEY 661_ FEKHR 666_ WPPVW 671_ YLKEE 676_ DHYQR 681_ ARKER 686_ EKEDY 691_ LHLKR 696_ QPKRR 701_ WLFWN 706_ SPSSP 711_ SSSAA 716_ SSSSP 721_SSSSA
1: Regulator of cell proliferation and apoptosis (PubMed:21801820). It likely functions as a substrate-adapter that recruits key substrates, e.g. MSI2, to CUL3-based ubiquitin ligase complexes for degradation (PubMed:15107402, PubMed:27941885). Required for MSI2 ubiquitination and degradation (PubMed:27941885)